Publications by authors named "Schoebel C"

Purpose: In heart failure (HF) and chronic obstructive pulmonary disease (COPD) populations, sleep-disordered breathing (SDB) is associated with impaired health outcomes. We evaluated whether in patients with HF, concomitant HF and COPD or COPD, the number of hospitalizations would be reduced in the year after testing for SDB with and without treatment initiation compared to the year before.

Methods: We performed a multicentre retrospective study of 390 consecutive sleep-clinic patients who had a primary diagnosis of chronic HF, HF and COPD or COPD and a secondary diagnosis of SDB.

View Article and Find Full Text PDF

Rationale: Adherence to positive airway pressure (PAP) therapy is a common and challenging issue. Although some studies have looked at the impact of initial mask selection, there is a lack of data regarding the impact of a change in mask on adherence to PAP therapy.

Objective(s): This study investigated the impact of a mask change or renewal on mid-term PAP adherence.

View Article and Find Full Text PDF

Purpose: The diagnostic workup for assessment of sleep disorders commonly involves overnight testing to assess sleep patterns and pathological events. So far, little is known about preferences for provision of home sleep tests to patients with sleep disorders. This study aims to close this gap by eliciting preferences for home sleep testing using a discrete choice experiment (DCE).

View Article and Find Full Text PDF

Purpose: The cardiorespiratory polysomnography (PSG) is an expensive and limited resource. The Sleepiz One + is a novel radar-based contactless monitoring device that can be used e.g.

View Article and Find Full Text PDF

Background: Telemonitoring-guided interventions can improve short-term positive airway pressure (PAP) therapy adherence, but long-term effects are unknown. This study investigated long-term PAP therapy termination in patients with sleep apnoea managed with standard care, telemonitoring-guided proactive care or telemonitoring-guided proactive care + patient engagement tool.

Methods: German healthcare provider data were analysed retrospectively.

View Article and Find Full Text PDF

Background: Breathing-synchronized hypoglossal nerve stimulation (HNS) is routinely used as an alternative treatment for patients with obstructive sleep apnea (OSA). Significant and clinically relevant improvements in disease severity and OSA symptoms such as daytime sleepiness as well as overall quality of life have been reported in randomized-controlled trials and large real-world cohort studies. However, so far, few data exist on patient-reported experience with the treatment.

View Article and Find Full Text PDF

Introduction: Hypoglossal nerve stimulation (HNS) has recently been introduced as an alternative treatment for patients with OSA. A large number of studies have demonstrated substantial changes in OSA with this therapy by reducing respiratory events and improving symptoms such as daytime sleepiness and quality of life. The objective of this review was to conduct a systematic review and meta-analysis to evaluate patient-reported outcomes and experience with HNS therapy.

View Article and Find Full Text PDF
Article Synopsis
  • Obstructive sleep apnea (OSA), nocturnal hypoxemia, and excessive daytime sleepiness (EDS) are frequently observed in adults with cystic fibrosis (pwCF), highlighting the need for better understanding of sleep-related issues.* -
  • In a study of 52 adult pwCF, 40% exhibited abnormal apnea-hypopnea indices, with 25% experiencing nocturnal hypoxemia, while 15% reported significant EDS as measured by the Epworth Sleepiness Scale.* -
  • Despite the prevalence of these sleep disorders, no strong predictive factors were identified; the study recommends routine sleep assessments (polysomnography and Epworth Sleepiness Scale) for adult pwCF regardless of their general health
View Article and Find Full Text PDF

Aims: Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing prevalence. Sleep-disordered breathing (SDB) is an important co-morbidity in HFpEF. The SchlaHF-XT registry evaluated the sex-specific prevalence and predictors of SDB, including obstructive (OSA) and central sleep apnoea, in patients with HFpEF compared with heart failure with mildly reduced (HFmrEF) or reduced (HFrEF) ejection fraction.

View Article and Find Full Text PDF
Article Synopsis
  • People with cystic fibrosis (pwCF) often experience sleep-disordered breathing (SDB) and disturbed sleep, which are frequently overlooked.
  • A study was conducted to assess the impact of the CFTR triple combination therapy, elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA), on sleep quality and related parameters in adult pwCF, using polysomnography before and after starting the treatment.
  • Results showed significant improvements in lung function, body mass index (BMI), and a decrease in sleep-disordered breathing metrics, while other sleep measures like total sleep time and efficiency remained unchanged.
View Article and Find Full Text PDF

Background: global trade in living plants and plant material has significantly increased the geographic distribution of many plant pathogens. As a consequence, several pathogens have been first found and described in their introduced range where they may cause severe damage on naïve host species. Knowing the center of origin and the pathways of spread of a pathogen is of importance for several reasons, including identifying natural enemies and reducing further spread.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is one of the most common chronic sleep disorders, which can be treated by different interventions. It is known that acceptance and adherence to these therapies is influenced by a variety of factors. However, there is a limited understanding of patient preferences and decision-making in the context of OSA treatment.

View Article and Find Full Text PDF

Background: Patients with obstructive sleep apnea (OSA) most commonly receive positive airway pressure therapy (PAP) as primary treatment, which is highly effective when used consistently. Little is known about the preferences for and relevance of attributes of OSA treatments, especially of non-PAP alternatives. The aim of this study was to evaluate treatment preferences and willingness to pay (WTP) among patients with and without previous experience of OSA therapies.

View Article and Find Full Text PDF

Purpose Of Review: The COVID-19 pandemic has clearly demonstrated that the technological progress in digitization is also essential for the medical sector. In the field of sleep-disordered breathing, the novel eHealth methods already do offer smart solutions for currently insufficiently addressed problems.

Recent Findings: In general, the potential of telemedicine tools can be focused on three basic aspects: interaction between clinicians, interaction between clinician and patient, and interaction between patient and the mobile health technology.

View Article and Find Full Text PDF
Article Synopsis
  • * An interventional clinical trial was conducted, measuring HRV before and after patients received three months of BiPAP treatment, showcasing significant relationships between hypoventilation and HRV.
  • * The study concludes that improved respiration from BiPAP may enhance the functioning of the autonomic nervous and cardiovascular systems, suggesting HRV metrics as useful for monitoring cardiovascular risks associated with OHS.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how sleep duration and quality relate to blood pressure and heart rate variability among university hospital staff in Isfahan, Iran.
  • Researchers used various measures, including the Pittsburgh Sleep Quality Index, to evaluate sleep quality and employed time domain spectral analysis for heart rate variability.
  • Results indicated that poor sleep quality linked to lower heart rate variability and elevated heart rate and blood pressure, highlighting the negative impact of inadequate sleep on cardiovascular health.
View Article and Find Full Text PDF

Central Sleep Apnea with Cheyne Stokes Respiration (CSA-CSR) is often diagnosed in patients with chronic heart failure (CHF). CSA-CSR displays a periodic breathing pattern with a typical waxing and waning breathing with central sleep apnea phases in between. Optimization of heart failure medication with Angiotensin receptor neprilysin inhibition (ARNi) can effect phenotypic traits of CSA-CSR indicating improvements of both, hemodynamic parameters and central chemosensitivity.

View Article and Find Full Text PDF

Patients with a wide variety of cardiovascular diseases, including arterial and pulmonary hypertension, arrhythmia, coronary artery disease and heart failure, are more likely to report impaired sleep with reduced sleep duration and quality, and also, sometimes, sleep interruptions because of paroxysmal nocturnal dyspnoea or arrhythmias. Overall, objective short sleep and bad sleep quality (non-restorative sleep) and subjective long sleep duration are clearly associated with major cardiovascular diseases and fatal cardiovascular outcomes. Sleep apnoea, either obstructive or central in origin, represents the most prevalent, but only one, of many sleep-related disorders in cardiovascular patients.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is a common health issue with serious complications. Regarding the high cost of the polysomnography (PSG), sensitive and inexpensive screening tools are necessary. The objective of this study was to evaluate the predictive value of anthropometric and Mallampati indices for OSA severity in both genders.

View Article and Find Full Text PDF

Background: Nowadays, the most practical approaches used to treat sleep apnea, are Continuous Positive Airway Pressure (CPAP), Bi-level Positive Airway Pressure therapy (BPAP), supplemental O, servoventilation and/or a combination of these approaches simultaneously. However, each leads to different consequences in opioid related Central Sleep Apnea (CSA) patients. Given the high prevalence of CSA and frequently use of opioids worldwide, it seems that evaluation of the condition in these patients is required to determine their responsiveness to the above mentioned treatments and to choose the most appropriate therapy.

View Article and Find Full Text PDF

is a native fungus in Europe where it behaves as a harmless decomposer of leaves of common ash. Its close relative was introduced into Europe from Asia and currently threatens ash ( sp.) stands all across the continent causing ash dieback.

View Article and Find Full Text PDF

Cheyne-Stokes respiration (CSR) is a periodic, highly dynamic, respiratory pattern and a known comorbidity in congestive heart failure (CHF) patients. It is generally seen as an indicator for a negative prognosis, even if no distinction in degree is known or understood. This paper aims to improve on existing attempts by creating a quantification of the behavior of the dynamic desaturation process of oxygen in the blood.

View Article and Find Full Text PDF
Article Synopsis
  • Remote patient management for heart failure patients aims to detect early signs of heart issues to initiate timely treatment and improve outcomes.
  • The TIM-HF2 trial involved over 1500 patients with heart failure, randomly assigning them to receive either remote patient management alongside usual care or usual care alone.
  • The study's primary goal was to measure the impact on hospitalization and mortality over nearly a year, and it has been registered with ClinicalTrials.gov.
View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is a common disorder characterized by snoring, daytime sleepiness, fatigue, and repeated termination of airflow (apnea). Standard polysomnography (PSG) is diagnostic gold standard for OSA. PSG is expensive and not available everywhere.

View Article and Find Full Text PDF

Hymenoscyphus fraxineus mitovirus 1 (HfMV1) occurs in the fungus Hymenoscyphus fraxineus, an introduced plant pathogen responsible for the devastating ash dieback epidemic in Europe. Here, we explored the prevalence and genetic structure of HfMV1 to elucidate the invasion history of both the virus and the fungal host. A total of 1298 H.

View Article and Find Full Text PDF